The EU is proposing to reduce regulations on clinical trials of drugs.

The biggest problem with clinical trials today is that they are run by the drug companies that make the drugs. This is a form of corruption. One specific aspect of this problem is that many trials go unpublished.

"Lighter regulation" on clinical trials does not sound like it would do anything to improve this. Indeed, it could make things worse. What we need is specific additional regulation.

This article gives too little information to judge the change, and that itself is a cause for suspicion.